Literature DB >> 32233993

What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.

Naziheh Assarzadegan1, Elizabeth Montgomery1.   

Abstract

CONTEXT.—: The 5th edition of the World Health Organization classification of digestive system tumors discusses several advancements and developments in understanding the etiology, pathogenesis, and diagnosis of several digestive tract tumors. OBJECTIVE.—: To provide a summary of the updates with a focus on neuroendocrine neoplasms, appendiceal tumors, and the molecular advances in tumors of the digestive system. DATA SOURCES.—: English literature and personal experiences. CONCLUSIONS.—: Some of the particularly important updates in the 5th edition are the alterations made in the classification of neuroendocrine neoplasms, understanding of pathogenesis of appendiceal tumors and their precursor lesions, and the expanded role of molecular pathology in establishing an accurate diagnosis or predicting prognosis and response to treatment.

Entities:  

Mesh:

Year:  2021        PMID: 32233993      PMCID: PMC9281538          DOI: 10.5858/arpa.2019-0665-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.686


  78 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

Review 2.  Recommendations for management of patients with neuroendocrine liver metastases.

Authors:  Andrea Frilling; Irvin M Modlin; Mark Kidd; Christopher Russell; Stefan Breitenstein; Riad Salem; Dik Kwekkeboom; Wan-yee Lau; Catherine Klersy; Valerie Vilgrain; Brian Davidson; Mark Siegler; Martyn Caplin; Enrico Solcia; Richard Schilsky
Journal:  Lancet Oncol       Date:  2014-01       Impact factor: 41.316

Review 3.  Carcinoid tumor of the esophagus: a clinicopathologic study of four cases.

Authors:  Mai P Hoang; Christine M Hobbs; Leslie H Sobin; Jorge Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

Review 4.  Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.

Authors:  Ting-Ting Li; Feng Qiu; Zhi Rong Qian; Jun Wan; Xiao-Kun Qi; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

5.  Neuroendocrine Carcinoma of Gallbladder: A Step Beyond Palliative Therapy, Experience of 25 Cases.

Authors:  Amol Vijay Kanetkar; Shraddha Patkar; Krunal Harischandra Khobragade; Vikas Ostwal; Anant Ramaswamy; Mahesh Goel
Journal:  J Gastrointest Cancer       Date:  2019-06

6.  HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

Authors:  Angela N Bartley; Mary Kay Washington; Carol Colasacco; Christina B Ventura; Nofisat Ismaila; Al B Benson; Alfredo Carrato; Margaret L Gulley; Dhanpat Jain; Sanjay Kakar; Helen J Mackay; Catherine Streutker; Laura Tang; Megan Troxell; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2016-11-14       Impact factor: 44.544

Review 7.  Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.

Authors:  Andrew M Bellizzi
Journal:  Semin Diagn Pathol       Date:  2013-11-13       Impact factor: 3.464

8.  Small cell carcinoma of the anus in the setting of prior squamous dysplasia and carcinoma in situ.

Authors:  David M Marcus; Mark A Edgar; Natalyn N Hawk; Patrick S Sullivan; Liza J Stapleford
Journal:  J Gastrointest Oncol       Date:  2013-06

9.  Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.

Authors:  Bruna Estrozi; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.

Authors:  Hung-Chih Hsu; Tan Kien Thiam; Yen-Jung Lu; Chien Yuh Yeh; Wen-Sy Tsai; Jeng Fu You; Hsin Yuan Hung; Chi-Neu Tsai; An Hsu; Hua-Chien Chen; Shu-Jen Chen; Tsai-Sheng Yang
Journal:  Oncotarget       Date:  2016-04-19
View more
  18 in total

1.  Photoacoustic endoscopy and EUS: Shaking the future of multimodal endoscopy.

Authors:  Kai Zhang; Jianjun Qiu; Fan Yang; Jing Wang; Xinyue Zhao; Zhigang Wei; Nan Ge; Yunliang Chen; Siyu Sun
Journal:  Endosc Ultrasound       Date:  2022 Jan-Feb       Impact factor: 5.628

Review 2.  Neuroendocrine Tumors: a Relevant Clinical Update.

Authors:  Emma N Rizen; Alexandria T Phan
Journal:  Curr Oncol Rep       Date:  2022-03-07       Impact factor: 5.075

Review 3.  Diagnosis and Surgical Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: A Literature Review.

Authors:  Shuzo Kohno
Journal:  Cancer Diagn Progn       Date:  2022-03-03

4.  Comparative Outcomes of Second-line Topoisomerase-I Inhibitor Therapies on Neuroendocrine Carcinoma.

Authors:  Ho-Man Yeung; Krishnalatha Sreekrishnanilayam; Caitlin Meeker; Mengying Deng; Sonali Agrawal; Haaris Abdullah; Namrata Vijayvergia
Journal:  J Gastrointest Cancer       Date:  2022-01-10

Review 5.  Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Meng Dai; Christina S Mullins; Lili Lu; Guido Alsfasser; Michael Linnebacher
Journal:  World J Gastrointest Surg       Date:  2022-05-27

6.  The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma.

Authors:  Xiangpan Li; Yuxin Chu; Qibin Song; Qinyong Hu
Journal:  J Oncol       Date:  2022-05-28       Impact factor: 4.501

7.  Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.

Authors:  Yu-Chen Huang; Ning-Ning Yang; Hong-Chun Chen; Yuan-Li Huang; Wen-Tian Yan; Ru-Xue Yang; Nan Li; Shan Zhang; Pan-Pan Yang; Zhen-Zhong Feng
Journal:  World J Gastroenterol       Date:  2021-02-21       Impact factor: 5.742

Review 8.  An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Jiayun M Fang; Jay Li; Jiaqi Shi
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.374

9.  Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer.

Authors:  Li-Ping Ye; Xin-Li Mao; Xian-Bin Zhou; Yi Wang; Shi-Wen Xu; Sai-Qin He; Zi-Liang Qian; Xiao-Gang Zhang; Li-Juan Zhai; Jin-Bang Peng; Bin-Bin Gu; Xiu-Xiu Jin; Ya-Qi Song; Shao-Wei Li
Journal:  World J Gastrointest Oncol       Date:  2022-03-15

10.  Primary hepatic neuroendocrine tumor.

Authors:  Le Tuan Linh; Nguyen Minh Duc; Hoang Tu Minh; Nguyen Ngoc Cuong; Vuong Thu Ha; Dao-Thi Luan; Thieu-Thi Tra My; Bui Van Lenh
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.